Atos missed its annual revenue forecast on Wednesday, dented by contract terminations and market weakness, but saw improved ...

Atos missed its annual revenue forecast on Wednesday, dented by contract terminations and market weakness, but saw improved ...

Belmer is now planning to retire in September as his current role would change significantly if the company splits. Atos has already determined who would lead the future Atos and Evidian.

Atos used its fiscal 2022 first half financial report to unveil the securing of a new debt package to help finance the company through its split into two separate global solution providers later ...

In a statement to the Paris Stock Exchange, Atos said this morning "it has been ... Previous management hatched a plan to split the business into two back in 2022 with the legacy components ...

To report any concerns or inaccuracies, please contact us at [email protected]. The post ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023 appeared first on InvestorPlace.

French reseller giant Atos has entered negotiations to sell its Tech Foundations ... as evidenced by the 119 per cent book-to-bill in Q2 2023. Following the split, Eviden would carry out its own ...

French digital transformation giant, Atos, has reported another drop in revenue as negotiations for the split and sale of part of the business go forward. In Q3 2023, Atos reported group revenue of €2 ...

Atossa Therapeutics, Inc. (ATOS) stock price is 0.77 and Atossa Therapeutics, Inc. (ATOS) 10-day simple moving average is 0.86. Atossa Therapeutics, Inc. (ATOS) stock price is 0.77 and Atossa ...